Is Nutra Pharma Corp. (NPHC) a Buy, Sell, or Hold?
OTC : NPHC
Nutra Pharma Corp.
$0.0003 USD
$0 (0.0%)
- Volume
- 688
- Average Volume
- 569.61K
- Market Capitalization
- $2.15M
- P/E Ratio
- -1.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.03
Company Overview
OTC
Michael D. Flax
Drug Manufacturers - Specialty & Generic
Healthcare
NPHC
7
US
USD
Liquidity Metrics
-0.58
0.03
0.03
0.00
0.00
Sales & Valuation
$385.31K
8.36
-0.14
-1.98
0.00
Profitability
-$0.0003
-$2.05M
-428.76%
-428.76%
6.65%
-178.77%
P/E Metrics
-1.00
0.02
0.02
Analyst Price Target & Rating
1/5
0 Analysts
%
Poll Results
About Nutra Pharma Corp. (OTC:NPHC) Stock
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic ... , and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.
Frequently Asked Questions
-
What is the current Nutra Pharma Corp. (NPHC) stock price?
-
Nutra Pharma Corp.(OTC:NPHC) stock price is $0.0003 in the last trading session. During the trading session, NPHC stock reached the peak price of $0.005 while $0.0001 was the lowest point it dropped to. The percentage change in NPHC stock occurred in the recent session was 0.0% while the dollar amount for the price change in NPHC stock was $0.
-
NPHC's industry and sector of operation?
-
The OTC listed NPHC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of NPHC?
-
Joe Lucas | Vice President of Operations
Michael D. Flax | Chairman, Chief Executive Officer, President & Chief Financial Officer
Nina Goldstein | Secretary
Dale VanderPutten | Chief Scientific Officer
| -
How many employees does NPHC have?
-
Number of NPHC employees currently stands at 7. NPHC operates from 1537 NW 65th Avenue, Boca Raton, FL 33313, US.
-
Link for NPHC official website?
-
Official Website of NPHC is: https://www.nutrapharma.com
-
How do I contact NPHC?
-
NPHC could be contacted at phone #954 509 0911 and can also be accessed through its website. NPHC operates from 1537 NW 65th Avenue, Boca Raton, FL 33313, US.
-
How many shares of NPHC are traded daily?
-
The average number of NPHC shares traded daily for last 3 months was 569.61K.
-
What is the market cap of NPHC currently?
-
The market value of NPHC currently stands at $2.15M with its latest stock price at $0.0003